ArticleAdvances in experimental medicine and biology2026
How the Intensity of Menopausal Symptoms Affects the Quality of Life in Menopausal Diabetic Women in Greece? A Cross-Sectional Study.
Article in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Menopause is a dynamic period of transition to reproductive ageing, resulting in menopausal symptoms with variable intensity, which affect women's daily life and psychosocial well-being. Purpose: To investigate the quality of life of menopausal women with diabetes mellitus and its correlation with the intensity of menopausal symptoms. A cross-sectional correlational study was conducted on 157 menopausal women with diabetes who completed three questionnaires: (a) a sociodemographic and clinical data questionnaire, (b) the Utian quality of life (UQOL) scale questionnaire, and c) the Symptom Scale Klaas Heinenmann's Menopause Rating Scale (MRS). The mean age of the participants was 52.4 years (SD = 3.5 years). More than half of the women (53.5%) had type 1 diabetes, while the largest percentage, 94.9%, was receiving medication. The main comorbidities observed in menopausal women with diabetes were hypertension (44.6%), thyroid diseases (38.9%), and hyperlipidemia (35.7%). The sample presented a low-to-moderate quality of life (mean value 68.3, SD = 15.5). The quality of life of menopausal women with diabetes appeared to be greatly reduced by the intensity of menopausal symptoms (p < 0.001) and coexisting comorbidities. According to the multivariable linear regression, as the age of menopausal women increased, their quality of life decreased (p = 0.001). Conclusions: As the intensity of menopausal symptoms negatively affects the quality of life of women with diabetes, the education of women should be a matter of high priority in primary health care. It is imperative to develop strategies not only to prevent but also treat women's menopausal symptoms.
Indexed as
Identifiers
41252013What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.